nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—SLC6A4—chronic obstructive pulmonary disease	0.79	1	CbGaD
Milnacipran—Levomilnacipran—SLC6A4—chronic obstructive pulmonary disease	0.00232	0.593	CrCbGaD
Milnacipran—Pethidine—SLC6A4—chronic obstructive pulmonary disease	0.00104	0.267	CrCbGaD
Milnacipran—Pethidine—ALB—chronic obstructive pulmonary disease	0.000549	0.14	CrCbGaD
Milnacipran—Tension—Formoterol—chronic obstructive pulmonary disease	0.000448	0.00217	CcSEcCtD
Milnacipran—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000448	0.00217	CcSEcCtD
Milnacipran—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000447	0.00217	CcSEcCtD
Milnacipran—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000447	0.00217	CcSEcCtD
Milnacipran—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000446	0.00216	CcSEcCtD
Milnacipran—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00215	CcSEcCtD
Milnacipran—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000442	0.00215	CcSEcCtD
Milnacipran—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000436	0.00211	CcSEcCtD
Milnacipran—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.000434	0.00211	CcSEcCtD
Milnacipran—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000433	0.0021	CcSEcCtD
Milnacipran—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000431	0.00209	CcSEcCtD
Milnacipran—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000431	0.00209	CcSEcCtD
Milnacipran—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000427	0.00207	CcSEcCtD
Milnacipran—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000427	0.00207	CcSEcCtD
Milnacipran—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000425	0.00206	CcSEcCtD
Milnacipran—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000424	0.00206	CcSEcCtD
Milnacipran—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.00205	CcSEcCtD
Milnacipran—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000422	0.00205	CcSEcCtD
Milnacipran—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000419	0.00203	CcSEcCtD
Milnacipran—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.00203	CcSEcCtD
Milnacipran—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000419	0.00203	CcSEcCtD
Milnacipran—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000417	0.00202	CcSEcCtD
Milnacipran—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000414	0.00201	CcSEcCtD
Milnacipran—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000411	0.00199	CcSEcCtD
Milnacipran—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000406	0.00197	CcSEcCtD
Milnacipran—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000403	0.00196	CcSEcCtD
Milnacipran—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000403	0.00196	CcSEcCtD
Milnacipran—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000403	0.00196	CcSEcCtD
Milnacipran—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.0004	0.00194	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000398	0.00193	CcSEcCtD
Milnacipran—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00192	CcSEcCtD
Milnacipran—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000395	0.00192	CcSEcCtD
Milnacipran—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000394	0.00191	CcSEcCtD
Milnacipran—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000394	0.00191	CcSEcCtD
Milnacipran—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000394	0.00191	CcSEcCtD
Milnacipran—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000389	0.00188	CcSEcCtD
Milnacipran—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000388	0.00188	CcSEcCtD
Milnacipran—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000388	0.00188	CcSEcCtD
Milnacipran—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000387	0.00188	CcSEcCtD
Milnacipran—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000387	0.00188	CcSEcCtD
Milnacipran—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000387	0.00188	CcSEcCtD
Milnacipran—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000387	0.00188	CcSEcCtD
Milnacipran—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000387	0.00188	CcSEcCtD
Milnacipran—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00187	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000386	0.00187	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.00187	CcSEcCtD
Milnacipran—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000381	0.00185	CcSEcCtD
Milnacipran—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00038	0.00184	CcSEcCtD
Milnacipran—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00038	0.00184	CcSEcCtD
Milnacipran—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000379	0.00184	CcSEcCtD
Milnacipran—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.00184	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000378	0.00183	CcSEcCtD
Milnacipran—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000377	0.00183	CcSEcCtD
Milnacipran—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000376	0.00182	CcSEcCtD
Milnacipran—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000372	0.0018	CcSEcCtD
Milnacipran—Infection—Formoterol—chronic obstructive pulmonary disease	0.00037	0.00179	CcSEcCtD
Milnacipran—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00037	0.00179	CcSEcCtD
Milnacipran—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000367	0.00178	CcSEcCtD
Milnacipran—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000366	0.00178	CcSEcCtD
Milnacipran—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.00177	CcSEcCtD
Milnacipran—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000365	0.00177	CcSEcCtD
Milnacipran—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000365	0.00177	CcSEcCtD
Milnacipran—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000365	0.00177	CcSEcCtD
Milnacipran—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000363	0.00176	CcSEcCtD
Milnacipran—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.00176	CcSEcCtD
Milnacipran—Infection—Montelukast—chronic obstructive pulmonary disease	0.000362	0.00176	CcSEcCtD
Milnacipran—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000362	0.00175	CcSEcCtD
Milnacipran—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000362	0.00175	CcSEcCtD
Milnacipran—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00036	0.00175	CcSEcCtD
Milnacipran—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.00174	CcSEcCtD
Milnacipran—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000358	0.00173	CcSEcCtD
Milnacipran—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000357	0.00173	CcSEcCtD
Milnacipran—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000357	0.00173	CcSEcCtD
Milnacipran—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000354	0.00172	CcSEcCtD
Milnacipran—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000349	0.00169	CcSEcCtD
Milnacipran—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000348	0.00169	CcSEcCtD
Milnacipran—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000348	0.00169	CcSEcCtD
Milnacipran—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000346	0.00168	CcSEcCtD
Milnacipran—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.00168	CcSEcCtD
Milnacipran—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.00167	CcSEcCtD
Milnacipran—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00166	CcSEcCtD
Milnacipran—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.00166	CcSEcCtD
Milnacipran—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00034	0.00165	CcSEcCtD
Milnacipran—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.00165	CcSEcCtD
Milnacipran—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000337	0.00163	CcSEcCtD
Milnacipran—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000337	0.00163	CcSEcCtD
Milnacipran—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000335	0.00163	CcSEcCtD
Milnacipran—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000335	0.00162	CcSEcCtD
Milnacipran—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000332	0.00161	CcSEcCtD
Milnacipran—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000332	0.00161	CcSEcCtD
Milnacipran—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000331	0.00161	CcSEcCtD
Milnacipran—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000331	0.00161	CcSEcCtD
Milnacipran—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00033	0.0016	CcSEcCtD
Milnacipran—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000328	0.00159	CcSEcCtD
Milnacipran—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.00159	CcSEcCtD
Milnacipran—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000328	0.00159	CcSEcCtD
Milnacipran—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000327	0.00159	CcSEcCtD
Milnacipran—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000326	0.00158	CcSEcCtD
Milnacipran—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000324	0.00157	CcSEcCtD
Milnacipran—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000323	0.00157	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.00156	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000321	0.00156	CcSEcCtD
Milnacipran—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000321	0.00156	CcSEcCtD
Milnacipran—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.00156	CcSEcCtD
Milnacipran—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000321	0.00156	CcSEcCtD
Milnacipran—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000318	0.00154	CcSEcCtD
Milnacipran—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000318	0.00154	CcSEcCtD
Milnacipran—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.00154	CcSEcCtD
Milnacipran—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.00153	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000315	0.00153	CcSEcCtD
Milnacipran—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000314	0.00152	CcSEcCtD
Milnacipran—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.00152	CcSEcCtD
Milnacipran—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.00152	CcSEcCtD
Milnacipran—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000311	0.00151	CcSEcCtD
Milnacipran—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.0015	CcSEcCtD
Milnacipran—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000308	0.0015	CcSEcCtD
Milnacipran—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000308	0.00149	CcSEcCtD
Milnacipran—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000306	0.00149	CcSEcCtD
Milnacipran—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.00148	CcSEcCtD
Milnacipran—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000305	0.00148	CcSEcCtD
Milnacipran—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000304	0.00148	CcSEcCtD
Milnacipran—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.00148	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.00147	CcSEcCtD
Milnacipran—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.00147	CcSEcCtD
Milnacipran—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000301	0.00146	CcSEcCtD
Milnacipran—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000298	0.00145	CcSEcCtD
Milnacipran—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00143	CcSEcCtD
Milnacipran—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00143	CcSEcCtD
Milnacipran—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00143	CcSEcCtD
Milnacipran—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00143	CcSEcCtD
Milnacipran—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00143	CcSEcCtD
Milnacipran—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00143	CcSEcCtD
Milnacipran—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000293	0.00142	CcSEcCtD
Milnacipran—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000291	0.00141	CcSEcCtD
Milnacipran—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000291	0.00141	CcSEcCtD
Milnacipran—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000291	0.00141	CcSEcCtD
Milnacipran—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00141	CcSEcCtD
Milnacipran—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000289	0.0014	CcSEcCtD
Milnacipran—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000288	0.0014	CcSEcCtD
Milnacipran—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000288	0.0014	CcSEcCtD
Milnacipran—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.00139	CcSEcCtD
Milnacipran—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000284	0.00138	CcSEcCtD
Milnacipran—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00135	CcSEcCtD
Milnacipran—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00135	CcSEcCtD
Milnacipran—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00135	CcSEcCtD
Milnacipran—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000274	0.00133	CcSEcCtD
Milnacipran—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.00133	CcSEcCtD
Milnacipran—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000274	0.00133	CcSEcCtD
Milnacipran—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000273	0.00133	CcSEcCtD
Milnacipran—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000269	0.0013	CcSEcCtD
Milnacipran—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000267	0.0013	CcSEcCtD
Milnacipran—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000267	0.0013	CcSEcCtD
Milnacipran—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000263	0.00128	CcSEcCtD
Milnacipran—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000263	0.00128	CcSEcCtD
Milnacipran—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000262	0.00127	CcSEcCtD
Milnacipran—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000259	0.00126	CcSEcCtD
Milnacipran—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00126	CcSEcCtD
Milnacipran—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000258	0.00125	CcSEcCtD
Milnacipran—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000255	0.00124	CcSEcCtD
Milnacipran—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000255	0.00124	CcSEcCtD
Milnacipran—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.00122	CcSEcCtD
Milnacipran—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000249	0.00121	CcSEcCtD
Milnacipran—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.00121	CcSEcCtD
Milnacipran—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.00119	CcSEcCtD
Milnacipran—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000246	0.00119	CcSEcCtD
Milnacipran—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000241	0.00117	CcSEcCtD
Milnacipran—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000241	0.00117	CcSEcCtD
Milnacipran—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.00117	CcSEcCtD
Milnacipran—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000237	0.00115	CcSEcCtD
Milnacipran—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000237	0.00115	CcSEcCtD
Milnacipran—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.00115	CcSEcCtD
Milnacipran—Rash—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00114	CcSEcCtD
Milnacipran—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00114	CcSEcCtD
Milnacipran—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000234	0.00114	CcSEcCtD
Milnacipran—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.00114	CcSEcCtD
Milnacipran—Headache—Formoterol—chronic obstructive pulmonary disease	0.000233	0.00113	CcSEcCtD
Milnacipran—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.00113	CcSEcCtD
Milnacipran—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000233	0.00113	CcSEcCtD
Milnacipran—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000233	0.00113	CcSEcCtD
Milnacipran—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00113	CcSEcCtD
Milnacipran—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000232	0.00112	CcSEcCtD
Milnacipran—Rash—Montelukast—chronic obstructive pulmonary disease	0.00023	0.00112	CcSEcCtD
Milnacipran—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00023	0.00111	CcSEcCtD
Milnacipran—Headache—Montelukast—chronic obstructive pulmonary disease	0.000228	0.00111	CcSEcCtD
Milnacipran—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00108	CcSEcCtD
Milnacipran—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00107	CcSEcCtD
Milnacipran—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000222	0.00107	CcSEcCtD
Milnacipran—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.00107	CcSEcCtD
Milnacipran—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00107	CcSEcCtD
Milnacipran—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00107	CcSEcCtD
Milnacipran—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00107	CcSEcCtD
Milnacipran—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.00105	CcSEcCtD
Milnacipran—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000217	0.00105	CcSEcCtD
Milnacipran—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.00104	CcSEcCtD
Milnacipran—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.00103	CcSEcCtD
Milnacipran—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00101	CcSEcCtD
Milnacipran—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000205	0.000995	CcSEcCtD
Milnacipran—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000983	CcSEcCtD
Milnacipran—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.000962	CcSEcCtD
Milnacipran—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.000954	CcSEcCtD
Milnacipran—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.000945	CcSEcCtD
Milnacipran—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000935	CcSEcCtD
Milnacipran—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000928	CcSEcCtD
Milnacipran—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000907	CcSEcCtD
Milnacipran—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.000884	CcSEcCtD
Milnacipran—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.000878	CcSEcCtD
Milnacipran—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000876	CcSEcCtD
Milnacipran—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000871	CcSEcCtD
Milnacipran—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000169	0.000821	CcSEcCtD
Milnacipran—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000165	0.0008	CcSEcCtD
Milnacipran—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000781	CcSEcCtD
Milnacipran—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.000777	CcSEcCtD
Milnacipran—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000765	CcSEcCtD
Milnacipran—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000754	CcSEcCtD
Milnacipran—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000752	CcSEcCtD
Milnacipran—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000739	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000736	CcSEcCtD
Milnacipran—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00072	CcSEcCtD
Milnacipran—Infection—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000706	CcSEcCtD
Milnacipran—Shock—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000699	CcSEcCtD
Milnacipran—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000697	CcSEcCtD
Milnacipran—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000694	CcSEcCtD
Milnacipran—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00069	CcSEcCtD
Milnacipran—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000687	CcSEcCtD
Milnacipran—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000677	CcSEcCtD
Milnacipran—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.000647	CcSEcCtD
Milnacipran—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000643	CcSEcCtD
Milnacipran—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000638	CcSEcCtD
Milnacipran—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000626	CcSEcCtD
Milnacipran—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000618	CcSEcCtD
Milnacipran—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000617	CcSEcCtD
Milnacipran—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000616	CcSEcCtD
Milnacipran—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000613	CcSEcCtD
Milnacipran—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000613	CcSEcCtD
Milnacipran—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000608	CcSEcCtD
Milnacipran—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000581	CcSEcCtD
Milnacipran—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000581	CcSEcCtD
Milnacipran—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000565	CcSEcCtD
Milnacipran—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000562	CcSEcCtD
Milnacipran—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000562	CcSEcCtD
Milnacipran—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000524	CcSEcCtD
Milnacipran—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000105	0.00051	CcSEcCtD
Milnacipran—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000503	CcSEcCtD
Milnacipran—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000486	CcSEcCtD
Milnacipran—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.69e-05	0.00047	CcSEcCtD
Milnacipran—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.31e-05	0.000452	CcSEcCtD
Milnacipran—Rash—Prednisone—chronic obstructive pulmonary disease	9.24e-05	0.000448	CcSEcCtD
Milnacipran—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.23e-05	0.000448	CcSEcCtD
Milnacipran—Headache—Prednisone—chronic obstructive pulmonary disease	9.18e-05	0.000445	CcSEcCtD
Milnacipran—Nausea—Prednisone—chronic obstructive pulmonary disease	8.7e-05	0.000422	CcSEcCtD
